Inovio Biomedical Corporation CEO to Present at 2010 Biotechnology Industry Organization (BIO) International Convention

BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that its CEO, Dr. J. Joseph Kim, will present a corporate update on its DNA vaccines for influenza, HIV and cancer and its vaccine delivery technology on May 5th at 2:15 p.m. at the upcoming 2010 BIO International Convention. Hosted by the Biotechnology Industry Organization (BIO), the meeting will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.